TrovaGene Inc. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
25,836.90
27,293.80
67,493.00
37,893.10
8,225.80
11,453.10
Total Accounts Receivable
79.00
56.70
98.70
100.50
77.10
167.80
Other Current Assets
152.80
369.30
789.30
956.60
1,165.80
1,144.40
Total Current Assets
26,068.70
27,719.80
68,381.10
38,950.20
9,468.70
12,765.30
Net Property, Plant & Equipment
750.60
840.40
2,690.60
3,826.90
2,426.30
1,304.40
Other Assets
336.50
336.70
374.00
1,173.30
389.90
102.80
Total Assets
27,155.70
28,896.80
71,445.70
43,950.40
12,284.90
14,172.50
ST Debt & Current Portion LT Debt
198.20
1,898.50
5,225.80
2,360.10
1,331.50
Accounts Payable
286.60
747.80
1,040.90
1,130.50
825.20
Other Current Liabilities
1,524.10
1,841.80
1,934.40
4,306.60
1,789.00
Total Current Liabilities
2,008.90
4,488.20
8,201.10
7,797.30
3,945.80
Long-Term Debt
323.00
13,053.10
11,246.20
14,176.40
-
Other Liabilities
4,431.90
3,006.00
3,297.10
2,208.70
1,833.10
Total Liabilities
6,763.70
20,547.30
22,744.40
24,182.30
5,778.80
Common Equity (Total)
20,391.90
8,349.50
48,701.20
19,768.10
6,506.00
Total Shareholders' Equity
20,392.00
8,349.60
48,701.30
19,768.10
6,506.10
Total Equity
20,392.00
8,349.60
48,701.30
19,768.10
6,506.10
Liabilities & Shareholders' Equity
27,155.70
28,896.80
71,445.70
43,950.40
12,284.90
Preferred Stock (Carrying Value)
0.10
0.10
0.10
0.10
0.10

About TrovaGene

View Profile
Address
11055 Flintkote Avenue
San Diego California 92121
United States
Employees -
Website http://www.trovagene.com
Updated 07/08/2019
Trovagene, Inc. is a clinical-stage, precision medicine oncology therapeutics company. Its focuses on developing PCM-075, is a Polo-like Kinase 1 (PLK1) selective adenosine triphosphate (ATP) competitive inhibitor. The company was founded by Gabriel M.